Teams

Junk/test data

This is for testing purposes only

TransBioNet is the Translational Bioinformatics Network impulsed and coordinated by the Spanish National Bioinformatics Institute (INB) as a reference network of 35+ bioinformatics support units working at health care settings including Health Research Institutes (IIS) certified by the Carlos III Health Institute (ISCIII), and bioinformatics core facilities from biomedical research institutions. TransBioNet is an Excellence Thematic Network (Red de Excelencia Temática) recognized by the Spanish ...

TRE-FX is assembling leading technology providers from ELIXIR-UK and HDR UK, with three TRE providers and two leading analysis platforms to show through a real reference implementation how we can use secure Research Objects to move between TREs while still supporting the Five Safes principles that govern and protect patient data; all overseen by patient representatives.

We develop a suite of analysis pipelines that will run on every genome produced in Tree of Life, providing a central database of core results available for all.

We gather the high throughput sequence data as it is generated, run quality control analysis to make sure the data is good quality and from the expected species. We assemble the long read sequence data into long contiguous pieces, then use further long-range sequencing data to scaffold the data into chromosome scale blocks. We then manually curate the assembly and submit it to INSDC.

We also develop automated tools and pipelines to enable the high throughput required for ever growing number of ...

TRON (Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH) is an independent biopharmaceutical non-profit translational research organization pursuing new diagnostics and drugs for the treatment of cancer and other diseases with high medical need. We focus our transdisciplinary competencies in genomics and immunology to 1) develop novel platforms for the identification and validation of “omics”-based biomarkers and 2) for harnessing and ...